Demodex mites are tiny eight-legged parasites that mostly live in hair follicles and oil glands on your face, neck, or chest. As alarming as this may sound, they’re generally harmless.

Tarsus Pharmaceuticals (TARS) will present four distinct data sets highlighting the global prevalence and real-world patient burden of Demodex ...

The whole thing is a skit. There’s no real patient on the other end of the autofractor. But the optometrist is using the skit as an educational opportunity for viewers. The optometrist warns in the ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...

Tarsus Pharmaceuticals' Xdemvy (lotilaner) has become the first FDA-approved therapy for Demodex blepharitis, a condition that affects up to 25 million people in the US and can lead to red itchy ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...